News
Stay up to date on the latest news and tweets of the Pereira Lab!
The Knut and Alice Wallenberg Foundation (KAW) awards the Pereira Lab a project grant to support “Neoantigen discovery with cellular reprogramming”
Our team was awarded with a KAW project grant that aims to use dendritic cell reprogramming for neoantigen identification, forwarding an alternative to boost the efficiency of current immunotherapies based on vaccines and neoantigen-specific T cell therapies.
In Vivo Dendritic Cell Reprogramming for Cancer Immunotherapy
The Pereira Lab reports for the first time the in vivo reprogramming of cancer cells into type 1 conventional dendritic cells (cDC1s). The study was published in Science and showcases a new cancer immunotherapy modality.
Beatriz Vaz and Mariana Gonçalves awarded with PhD Studentships from The Foundation for Science and Technology (FCT)
The researchers Beatriz Vaz and Mariana Gonçalves from Pereira Lab were awarded with PhD studentships from the Foundation for Science and Technology (FCT). Both PhD projects aim to surpass the limitations of current cancer immunotherapies, addressing different strategies to reprogram cancer cells into antigen-presenting type 1 conventional dendritic cells (cDC1s), which are pivotal for anti-tumor immunity.